ATE112574T1 - Igg-bindendes protein h, kodierendes gen dafür und verfahren zu seiner herstellung. - Google Patents

Igg-bindendes protein h, kodierendes gen dafür und verfahren zu seiner herstellung.

Info

Publication number
ATE112574T1
ATE112574T1 AT89113430T AT89113430T ATE112574T1 AT E112574 T1 ATE112574 T1 AT E112574T1 AT 89113430 T AT89113430 T AT 89113430T AT 89113430 T AT89113430 T AT 89113430T AT E112574 T1 ATE112574 T1 AT E112574T1
Authority
AT
Austria
Prior art keywords
igg
production
binding protein
gene encoding
protein
Prior art date
Application number
AT89113430T
Other languages
English (en)
Inventor
Hideyuki Gomi
Tatsunobu Hozumi
Shizuo Hattori
Chiaki Tagawa
Fumitaka Kishimoto
Lars Bjoerck
Original Assignee
Sumitomo Pharma
Hightech Receptor Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharma, Hightech Receptor Ab filed Critical Sumitomo Pharma
Application granted granted Critical
Publication of ATE112574T1 publication Critical patent/ATE112574T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AT89113430T 1988-11-21 1989-07-21 Igg-bindendes protein h, kodierendes gen dafür und verfahren zu seiner herstellung. ATE112574T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29552788 1988-11-21
JP1058434A JP2871709B2 (ja) 1988-11-21 1989-03-09 免疫グロブリンｇ結合活性を有する新規な蛋白質プロテインｈ、該蛋白質をコードする遺伝子及び該蛋白質の製造法

Publications (1)

Publication Number Publication Date
ATE112574T1 true ATE112574T1 (de) 1994-10-15

Family

ID=26399494

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89113430T ATE112574T1 (de) 1988-11-21 1989-07-21 Igg-bindendes protein h, kodierendes gen dafür und verfahren zu seiner herstellung.

Country Status (7)

Country Link
US (2) US5180810A (de)
EP (1) EP0371199B1 (de)
JP (1) JP2871709B2 (de)
AT (1) ATE112574T1 (de)
CA (1) CA1338707C (de)
DE (1) DE68918673T2 (de)
ES (1) ES2061823T3 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6737521B1 (en) * 1990-05-11 2004-05-18 The Rockefeller University Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria
SE9002213D0 (sv) * 1990-06-21 1990-06-21 Hightech Receptor Ab Albumin binding proteins
SE9002212D0 (sv) * 1990-06-21 1990-06-21 Hightech Receptor Ab Igg binding protein
SE9201331D0 (sv) * 1992-04-28 1992-04-28 Hightech Receptor C O Active Protein l och hybridproteiner daerav
SE9503495L (sv) * 1995-10-09 1997-04-10 Actinova Ltd Nytt protein
GB9723825D0 (en) * 1997-11-11 1998-01-07 Actinova Ltd Nuclear targeting by means of bacterial proteins
GB9723824D0 (en) * 1997-11-11 1998-01-07 Actinova Ltd Cytostatic agents
GB9807890D0 (en) * 1998-04-09 1998-06-10 Actinova Ltd Peptides
JP2005112827A (ja) * 2003-10-10 2005-04-28 National Institute Of Advanced Industrial & Technology 抗体アフィニティ担体
US9505846B2 (en) * 2005-01-28 2016-11-29 Life Technologies Corporation Multi-component inhibitors of nucleic acid polymerases
EP2522755B1 (de) 2007-08-13 2014-04-02 Baxter International Inc. IVIg-Modulation von Chemokinen zur Behandlung von Multipler Sklerose, Morbus Alzheimer und Morbus Parkinson
TWI489994B (zh) * 2008-03-17 2015-07-01 Baxter Healthcare Sa 供免疫球蛋白及玻尿酸酶之皮下投藥之用的組合及方法
EP2356135B1 (de) 2008-11-05 2017-10-25 Wyeth LLC Immunogene multikomponentenzusammensetzung zur prävention einer erkrankung mit beta-hämolytischen streptokokken (bhs)
EP3708581A3 (de) 2009-05-27 2021-10-20 Takeda Pharmaceutical Company Limited Verfahren zur herstellung eines hochkonzentrierten immunglobulinpräparats zur subkutanen verwendung
CA2774053C (en) 2009-09-17 2015-04-28 Baxter Healthcare, S.A. Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
SG188487A1 (en) 2010-09-17 2013-05-31 Baxter Int Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral ph
KR20200126005A (ko) 2012-02-29 2020-11-05 박스알타 인코퍼레이티드 말초 신경의 IgG 자극된 재수초화

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5151350A (en) * 1982-10-27 1992-09-29 Repligen Corporation Cloned genes encoding recombinant protein a
US4757134A (en) * 1982-12-02 1988-07-12 The Rockefeller University IgA binding protein
US4883754A (en) * 1986-03-06 1989-11-28 University Of Florida Research Foundation Bacterial FC receptors

Also Published As

Publication number Publication date
US5180810A (en) 1993-01-19
US5278297A (en) 1994-01-11
ES2061823T3 (es) 1994-12-16
EP0371199A1 (de) 1990-06-06
EP0371199B1 (de) 1994-10-05
CA1338707C (en) 1996-11-12
JP2871709B2 (ja) 1999-03-17
DE68918673T2 (de) 1995-03-30
DE68918673D1 (de) 1994-11-10
JPH02231499A (ja) 1990-09-13

Similar Documents

Publication Publication Date Title
ATE112574T1 (de) Igg-bindendes protein h, kodierendes gen dafür und verfahren zu seiner herstellung.
DE262192T1 (de) Verfahren und mittel zur herstellung eines proteins mit dergleichen igg-spezifizitaet wie protein g.
ES2072892T3 (es) Proteina receptora para un factor 2 estimulante de celulas b humanas.
AU6733487A (en) Mammalian interleukin-4
DE3586189T2 (de) Menge und verfahren zur herstellung rekombinierter erzeugnisse in grosser ausbeute.
EP0293443A4 (de) Herstellung synthetischer dns und deren verwendung bei der synthese grosser polypeptide.
ATE320495T1 (de) Kalziumfreie subtilisin mutanten
DE3585953D1 (de) Dna-fragmente, expressionsvektoren, proteine, wirte und verfahren zur herstellung der proteine.
FI90667C (fi) Menetelmä valmistaa uutta ihmisen tyypin I interferoniproteiinia
EP0760849A4 (de) Rekombinante, aud bpi und lbp basierende proteine, die für sie kodierenden nukleinsäuren, verfahren zu ihrer herstellung und ihre verwendung
ATA192895A (de) Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen
ATE124724T1 (de) Penicillin-g-acylase, dafür kodierendes gen und verfahren zur herstellung von diesem enzym.
DE69534743D1 (de) FÜR DAS IgG-Fc-BINDENDE PROTEIN KODIERENDES GEN
DE3854420D1 (de) Onkogen kodierendes polypeptid, das wachstumsfaktoraktivität besitzt, verfahren zu seiner herstellung und verwendung.
GB2171703B (en) Expression-secretion vector for gene expression and protein secretion, recombinant dna including the vector, and method of producing proteins by use of the re
HUP9801330A2 (hu) Új PKA-kötő fehérjék és alkalmazásuk
IL89391A0 (en) Structural gene coding for an insecticidal endotoxin protein,said protein,its production and use of said gene and protein
ZA844989B (en) Proteins,pharmaceutical compositions,genes,vectors,host organisms and processes for their production
ATE103635T1 (de) Reg-gen und dadurch kodiertes protein.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee